GoodRx Holdings, Inc.
Healthcare sector | Health Information Services industry
Metrics for GDRX
| Price | $2.23 |
|---|---|
| Shares Outstanding | 108.61M |
| All-Time Low | $2.10 |
| 52-Week Low | $2.10 |
Balance Statement Metrics
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $-1.33 |
| Net Tangible Assets / Share | $0 |
| Shares Outstanding Ave Change (Annual) | -1.5% |
| Shares Δ YoY | -2.86% |
| Avg CA Burn (Annual %) | -15.03% (as of 3-8-2026) |
| Avg CA Burn (Quarterly %) | 0.08% (as of 3-8-2026) |
Earning Metrics
| Max Earning Power / Share | $4.19 |
|---|---|
| Adjusted Earning Power |
$0.48
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
3.09%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 94M (as of 3-8-2026) |
| Avg EBITDA (5Q) | 45.2M (as of 3-8-2026) |
| Avg Net Income (5Y) | -12.6M (as of 3-8-2026) |
| Avg Net Income (5Q) | 7.4M (as of 3-8-2026) |
Indicators
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 3-8-2026 |
| Consecutive Years Paid | No | 3-8-2026 |
| Pays Dividend | No | 3-8-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 3-8-2026 |
| Net Income Positive | Yes | 3-8-2026 |
| Current Dividend Streak | No | 3-8-2026 |
Metric History Explorer
Pick a metric to view its history table and chart.
Tangible Book Value Per Share History
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $-0.05 | -17.4M ($-17,412,000) | 341.1M (341,052,187) |
| 2025-09-30 | Quarterly | $-0.08 | -25.9M ($-25,898,000) | 341.2M (341,173,000) |
| 2025-06-30 | Quarterly | $0.05 | 17.5M ($17,459,000) | 352.8M (352,771,000) |
| 2025-03-31 | Quarterly | $0.09 | 33.7M ($33,693,000) | 360.8M (360,813,320) |
| 2024-12-31 | Quarterly | $0.36 | 137M ($137,006,000) | 382.8M (382,815,000) |
| 2024-12-31 | Annual | $0.36 | 137M ($137,006,000) | 382.8M (382,815,000) |
| 2024-09-30 | Quarterly | $0.29 | 111.7M ($111,706,000) | 380.8M (380,796,000) |
| 2023-12-31 | Annual | $0.49 | 194.9M ($194,852,000) | 394.1M (394,087,000) |
| 2022-12-31 | Annual | $0.54 | 212.8M ($212,773,000) | 397M (397,025,000) |
| 2021-12-31 | Annual | $0.92 | 368.2M ($368,206,000) | 400.6M (400,562,000) |
Revenue History (Annual)
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 792.3M ($792,324,000) |
| 2023-12-31 | 750.3M ($750,265,000) |
| 2022-12-31 | 766.6M ($766,554,000) |
| 2021-12-31 | 745.4M ($745,424,000) |
Dividend Payments
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
Shares Outstanding Changes
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-03-06 | 108,610,311 | +3,141,479 |
Short Interest Changes
Latest short-interest change: 9,212,055 shares (9.46% of float) | Days to cover: 2.39
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-25 | 9,212,055 shares | -1,723,516 | -15.76% |
| 2026-03-12 | 10,935,571 shares | +588,283 | +5.69% |
| 2026-02-27 | 10,347,288 shares | -464,821 | -4.30% |
| 2026-02-11 | 10,812,109 shares | +1,132,086 | +11.70% |
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.